QSR:NYSERestaurant Brands International Inc. Analysis
Data as of 2026-05-22 - not real-time
$76.25
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Restaurant Brands International posted Q1 earnings that beat consensus, with adjusted EPS of $0.86 and revenue growth of 7.3% YoY, reinforcing the company’s resilient top‑line momentum. Technical indicators show the 20‑day SMA comfortably above the 50‑day SMA, suggesting a short‑term bullish bias, while the MACD has turned bearish and volume is trending down, tempering enthusiasm. The stock is trading near its identified support around $74.8 and well below the recent resistance near $82, leaving limited upside in the near term. Momentum metrics such as an RSI in the mid‑40s indicate neither overbought nor oversold conditions, and a low beta points to modest price swings relative to the market. However, the 30‑day volatility approaching 27% signals notable price swings that could challenge tight‑range traders. The dividend yield of roughly 3.4% combined with an 80% payout ratio is sustainable given strong operating cash flow, though the balance sheet carries a high debt‑to‑equity ratio. A discounted cash flow model values the shares near $32, implying the current market price reflects a sizable premium. Analyst consensus remains “buy” with a mean target around $86, highlighting expectations for continued organic growth and upcoming buyback programs. Overall, the company blends solid earnings performance and cash generation with a valuation gap that warrants cautious optimism.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Earnings beat supports price stability
- Bearish MACD and decreasing volume limit upside
- Proximity to technical support level
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong revenue growth and operating margins
- Attractive dividend yield with sustainable payout
- Analyst consensus and upside potential to target price
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- Diversified brand portfolio provides resilience
- High debt level and valuation premium create headroom risk
- Consistent cash flow generation supports dividend and buybacks
Key Metrics & Analysis
Financial Health
Revenue Growth7.30%
Profit Margin9.96%
P/E Ratio24.5
ROE28.14%
ROA6.44%
Debt/Equity296.41
P/B Ratio7.1
Op. Cash Flow$1.7B
Free Cash Flow$1.6B
Technical Analysis
TrendBullish
RSI45.1
Support$74.79
Resistance$81.96
MA 20$78.23
MA 50$76.80
MA 200$69.99
MACDBearish
VolumeDecreasing
Fear & Greed Index91.11
Valuation
Fair Value$32.06
Target Price$85.89
Upside/Downside12.64%
GradeOvervalued
TypeGrowth
Dividend Yield3.41%
Risk Assessment
Beta0.27
Volatility26.99%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.